We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.38B
AUM Growth
-$236M
Cap. Flow
-$330M
Cap. Flow %
-23.99%
Top 10 Hldgs %
54.43%
Holding
96
New
13
Increased
16
Reduced
18
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$35.4M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$22.4M
3
BDX icon
Becton Dickinson
BDX
+$21.2M
4
BBIO icon
BridgeBio Pharma
BBIO
+$20.8M
5
OM icon
Outset Medical
OM
+$20.1M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$25.6M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$22.8M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$21.7M
4
LLY icon
Eli Lilly
LLY
+$20.7M
5
UNH icon
UnitedHealth
UNH
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 91.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.07T
$226M 16.42%
273,778
-24,865
-8% -$20.7M
ABBV icon
2
AbbVie
ABBV
$458B
$69.5M 5.05%
331,741
– –
THC icon
3
Tenet Healthcare
THC
$20.1B
$66.1M 4.8%
491,334
– –
MCK icon
4
McKesson
MCK
$98.5B
$65.6M 4.76%
97,498
– –
AXSM icon
5
Axsome Therapeutics
AXSM
$12.4B
$64.9M 4.71%
556,545
+89,118
+19% +$10.2M
XLV icon
6
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$62.7M 4.56%
429,700
-35,000
-8% -$5.08M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$121B
$61.6M 4.47%
126,989
– –
ISRG icon
8
Intuitive Surgical
ISRG
$121B
$46.1M 3.35%
93,073
– –
PEN icon
9
Penumbra
PEN
$12.5B
$44.5M 3.23%
166,261
– –
SLNO
10
DELISTED
Soleno Therapeutics
SLNO
$42.5M 3.09%
595,206
+287,703
+94% +$14M
ARGX icon
11
argenx
ARGX
$57.4B
$40.8M 2.97%
68,999
+5,300
+8% +$3.34M
ELV icon
12
Elevance Health
ELV
$81.9B
$38.4M 2.79%
+88,222
New +$35.4M
BBIO icon
13
BridgeBio Pharma
BBIO
$16.5B
$31.4M 2.28%
908,135
+617,893
+213% +$20.8M
UHS icon
14
Universal Health Services
UHS
$9.43B
$29.2M 2.12%
155,520
-58,463
-27% -$10.7M
ASND icon
15
Ascendis Pharma A/S
ASND
$16.7B
$29.1M 2.12%
186,916
+134,524
+257% +$19.2M
EW icon
16
Edwards Lifesciences
EW
$47.6B
$27.5M 2%
379,954
-214,218
-36% -$15.3M
HCA icon
17
HCA Healthcare
HCA
$84.8B
$26.8M 1.94%
77,464
+8,023
+12% +$2.58M
ALNY icon
18
Alnylam Pharmaceuticals
ALNY
$36.3B
$23.5M 1.71%
+87,145
New +$22.4M
MOH icon
19
Molina Healthcare
MOH
$10.3B
$23.1M 1.68%
70,088
– –
DHR icon
20
Danaher
DHR
$135B
$23.1M 1.67%
112,475
-13,040
-10% -$2.85M
CVS icon
21
CVS Health
CVS
$137B
$21.2M 1.54%
+312,305
New +$18.7M
BDX icon
22
Becton Dickinson
BDX
$43.1B
$21M 1.52%
+91,571
New +$21.2M
IQV icon
23
IQVIA
IQV
$34.7B
$19.7M 1.43%
111,854
– –
WAT icon
24
Waters Corp
WAT
$36.8B
$19.1M 1.39%
51,858
-7,195
-12% -$2.79M
UNH icon
25
UnitedHealth
UNH
$382B
$18.8M 1.37%
35,904
-39,684
-53% -$20.3M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q1 2025 Portfolio in Review

As of Q1 2025, PFM Health Sciences held 96 positions worth $1.38B, down 15% from $1.61B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

PFM Health Sciences withdrew a net $330M in Q1 2025, closing 30 positions and reducing 18 holdings. Its most notable exit was DexCom, an estimated $25.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 75% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Elevance Health worth $38.4M.

  • PFM Health Sciences's largest Q1 2025 buy was Elevance Health: 88,222 shares worth $38.4M.
  • PFM Health Sciences added most to BridgeBio Pharma in Q1 2025, an estimated $20.8M increase.
  • PFM Health Sciences's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $20.7M.
  • PFM Health Sciences fully exited DexCom in Q1 2025, selling an estimated $25.6M.
  • PFM Health Sciences's ten largest holdings make up 54% of its $1.38B portfolio in Q1 2025.
  • PFM Health Sciences opened 13 new positions and closed 30 in Q1 2025.
  • PFM Health Sciences's portfolio value fell 15% quarter-over-quarter to $1.38B.

Based on PFM Health Sciences's 13F filing for Q1 2025, filed 15 May 2025.